Antioxidant status in patients with acute myocardial infarction

Indian Journal of Clinical Biochemistry

Volumn 22, Issue 1, 2007, Pages 45-51

  Patil, Neela D ^a,b   Chavan, Vishwas ^a   Karnik, N D ^a  

^a LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL   (India)

^b LTMMC   (India)

Author keywords

Antioxidant; Inflammation and AMI; Oxidative stress

Indexed keywords

ADENOSINE DEAMINASE; ALPHA TOCOPHEROL; ASCORBIC ACID; CERULOPLASMIN; FIBRINOGEN; FREE RADICAL; GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLYCOSYLATED HEMOGLOBIN; LIPID; LYSOZYME; MALONALDEHYDE; SIALIC ACID; SUPEROXIDE DISMUTASE;

ACUTE HEART INFARCTION; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BLOOD ANALYSIS; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DISEASE MARKER; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN ANALYSIS;

EID: 33947155742     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02912880     Document Type: Article

References (36)

1. Carrol CE. Oxygen free radicals and human disease. Ann Int Med 1987; 107: 526-45.
2. Shrinivas K, Vijaya Bhaskar M , Aruna Kumari R , Nagaraj K, Reddy KK. Antioxidants, lipid peroxidation and lipoproteins in primary hypertension. Indian Heart J 2000; 52: 285-8.
3. Block G, Dietrich M, Norkus EP, Morrow JD, Hudes M, Cann B, et al. Factors associated with oxidative stress in human populations. Am J Epidemiol 2002 ; 156: 274-85.
4. Libby P. Vascular biology of atherosclerosis: Overview and state of art. Am J Cardiol 2003; 91(suppl): 3A-6A.
5. Beutler E, Duran O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963; 61(5): 882-8.
6. Paglia DE, Valentine WN. Studies on quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70:158-69.
7. Winterbourn CC, Hawkins RE, Brian M, Carrell RW. The estimation of red cell superoxide dismutase activity. J Lab Clin Med 1975; 85 (2): 337-41.
8. 1C. FEBS Lett 1976; 71: 356-60.
9. TH edition, Chapter 19, 557-8.
10. TH edition; Chapter 35: 927.
11. TH edition, Chapter 35: 902.
12. Sasikala M, Subramanyam C, Sadasivudu B. Early oxidative change in low density lipoproteins during progressive chronic renal failure. Ind J Clin Biochem 1999; 14(2); 176-83.
13. Ravin HA. An improved colorimetric enzymatic assay of ceruloplasmin. J Lab Clin Med 1961; 58(1): 161-8.
14. Martinek RG. Micromethod for estimation of serum adenosine deaminase. Clin Chem 1963; 9(5): 620-25.
15. Harrison JF, Lunt GS, Scott P, Blainey JD. Urinary lysozyme, ribonuclease and low molecular weight protein in renal disease. Lancet 1968; 1: 371-5.
16. Cabezas JA, Vazquez Porto J. Sialic acid in human serum. Clin Chem 1964; 10(11): 986-90.
17. Dubois-Rande JL, Artigou JY, Darmon JY, Habbal R, Manuel C, Tayarani I, et al. Oxidative stress in patients with unstable angina. Eur Heart J 1994; 15(2): 179-83.
18. McMurray J. Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J 1993; 14 (11): 1493-7.
19. Engstrom G, Stavenow L, Hedblad B, Lind P, Eriksson KF, Janzon L, et al. Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study. Diabetes 2003; 52 (2): 442-47.
20. Fox PL, Mukhopadhyay C, Ehrenwald E. Structure, oxidant activity, and cardiovascular mechanisms of human ceruloplasmin. Life-Sci 1995; 56 (21): 1749-58.
21. Singh RB, Niaz MA, Sharma JP, Kumar R, Bishnoi I, Begom R. Plasma levels of antioxidant vitamins and oxidative stress in patients with acute myocardial infarction. Acta Cardiol 1994; 49: 441-52.
22. Kharb S. Low blood glutathione levels in acute myocardial infarction. Ind J Med Sci 2003; 57 (8): 335-7.
23. Kumar KV, Das UN. Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Res Commun 1993; 19(1): 59-66.
24. Stec JJ, Silbershatz H, Tofler GH, Matheney TH, Sutherland P, Lipinska I et al. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham offspring population. Circulation 2000; 102(14): 1634-38.
25. Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease. JAMA-India 2004; 3 (2): 34-41.
26. Jose J, Selvakumar D, Selvakumar R, Kanagasapabathy AS, Jeyaseelan L. Plasma fibrinogen-an independent risk factor for ischemic heart disease. Ind Heart J 1998; 50(1): 45-8.
27. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease. JAMA 1987; 258 (9): 1183-6.
28. Acevedo M, Foody JM, Pearce GL, Sprecher DL. Fibrinogen: Association with cardiovascular events in an outpatient clinic. Am Heart J 2002; 143(2): 277-82.
29. Sari RA, Taysi S, Yilmaz O, Bakan N. Correlation of serum levels of adenosine deaminase activity and its isoenzymes with disease activity in rheumatoid arthritis. Clin Exp Rheumatol 2003; 21(1): 87-90.
30. Frode TS, Medeiros YS. Myeloperoxidase and adenosine deaminase levels in the pleural fluid leakage induced by carrageenan in the mouse model of pleurisy. Mediators Inflamm 2001; 10(4): 223-7.
31. Kurtul N, Pence S, Akarsu E, Kocoglu H, Aksoy Y, Aksoy H. Adenosine deaminase activity in the serum of type 2 diabetic patients. Acta Medica (Hradec Kralove) 2004; 47(1): 33-5.
32. Welman E, Colbeck JF, Selwyn AP, Fox KM, Orr I. Plasma lysosomal enzyme activity in acute myocardial infarction and the effects of drugs. Adv Myocardiol 1980; 2: 359-69.
33. Welman E, Selwyn AP, Peters TJ, Colbeck JF, Fox KM. Plasma lysosomal enzyme activity in acute myocardial infarction. Cardiovasc Res 1978; 12(2):99-105.
34. Hickey NC, Gosling P, Barr S, Shearman CP, Simms MH. Effect of surgery on the systemic inflammatory response to intermittent claudication. Br J Surg 1990; 77 (10): 1121-4.
35. Crook MA, Goldsmith L, Ameerally P, Lumb P, Singh N, Miell J, et al. Serum sialic acid, a possible cardiovascular risk factor is not increased in Fijian Melanesians with impaired glucose tolerance or impaired fasting glucose. Ann Clin Biochem 2002; 39 (6): 606-8.
36. Haffner SM. Do interventions to reduce coronary heart disease reduce the incidence of type 2 diabetes? A possible role for inflammatory factors. Circulation 2001; 103(3): 346-7.